MedPath

Efficacy of Memantine Add on Treatment in Obsessive Compulsive Disorder

Phase 3
Recruiting
Conditions
Obsessive-compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT20201227049851N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

All patients who suffer from obsessive-compulsive disorder according to DSM V and clinical interview.
Patients who have Yale-Brown Scores of 15 and above.
Patients who give written consent for participating in the study.

Exclusion Criteria

Patients who are diagnosed with a comorbid DSM V psychiatric diagnosis.
Patients who suffer from any systemic disease such as diabetes, hypo and hyperthyroidism,hypertension,hepatic failure or renal failure.
Patients who use alcohol or any other substance.
Patients who have received a psychotropic medicine during the last 6 months.
Women who are pregnant or breastfeeding or do not use any certain contraceptive method.
Patients who use concomitant somatic treatments.
Patients who are under treatment with Acetyl Cysteine, buprenorphine or any other medicine
Patients who receive any kind of psychotherapies.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath